Study of ZG005 Combined With Bevacizumab Versus Sintilimab Combined With Bevacizumab in Advanced Hepatocellular Carcinoma

Clinical trial NCT06558227 · RECRUITING

Trial details

NCT number: NCT06558227
Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2024-10-24
Primary completion: 2026-09-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.